If you care about Aging Powerfully, this is the conversation that changes everything.
What Dr. William Evans’ Research Means for Muscle-First Medicine
For decades, aging has been framed as an inevitable decline. Metabolism slows. Strength decreases. Function fades. The assumption has been that time itself is responsible.
Dr. William Evans, the scientist who first described sarcopenia, reframes that narrative. “Sarcopenia really refers to the age-related loss of muscle,” he explains. “The loss of muscle is what drives a reduced metabolic rate.”
This distinction changes everything. Aging is not the primary driver of metabolic decline. Muscle loss is. Muscle is not cosmetic tissue. It is metabolically active infrastructure. It regulates insulin sensitivity, glucose disposal, mechanical force production, and structural stability. When muscle declines, metabolic efficiency declines with it. When muscle is preserved, function follows.
The question shifts from: how old are you? To: how much muscle are you maintaining? 
Muscle Is Predictive of Outcomes
One of the major challenges in sarcopenia research has been measurement. Traditional tools such as bioimpedance and DXA measure lean body mass, not muscle specifically. Dr. Evans explains that in older adults, lean body mass is only about fifty percent muscle.
The remainder includes water, connective tissue, and organ mass.
This dilution explains why lean mass has not consistently predicted disability or mortality.
When muscle itself is measured accurately, the relationship becomes clear. Dr. Evans and his colleagues developed a non-invasive method using deuterated creatine to directly assess total muscle mass. In large cohort studies, measured muscle mass strongly correlated with strength, mobility disability risk, and mortality.
He states clearly, “The amount of muscle that you have is a powerful predictor of outcomes.” Muscle is not simply part of the body composition equation. It is a determinant of longevity and independence.
Muscle Is Adaptable at Any Age
When asked what myth about aging he would erase permanently, Dr. Evans answered without hesitation. “Sarcopenia is an inevitable consequence of aging? It is not.”
His laboratory demonstrated that individuals in their nineties were able to increase fast twitch fiber size through high intensity resistance training. Muscle remains responsive to stimulus, even in advanced age.
However, biology does shift. Around age thirty, motor units begin to decline and fast twitch fibers are preferentially lost. These fibers are responsible for strength and power production. Hormonal shifts, insulin resistance, and inactivity compound this process.
The decline is influenced by behavior and biology. It is not predetermined.
The Weight Loss Era Requires Muscle Protection
Modern weight loss approaches often overlook muscle preservation. Dr. Evans highlights the mechanism clearly. When caloric intake decreases, protein intake typically decreases as well. The result is a reduction in muscle protein synthesis.
Older adults are particularly vulnerable. They lose more muscle during weight loss and struggle to regain it afterward. He emphasizes that the most effective strategy includes resistance training and adequate high quality protein intake. Without these protections, weight loss may reduce metabolically active tissue, lower resting metabolic rate, and compromise long term resilience.
This context makes interventions that support muscle protein synthesis especially relevant.
Fortetropin and the Regulation of Muscle Protein Synthesis
During the conversation, Dr. Evans discussed clinical research his team conducted evaluating Fortetropin, the bioactive ingredient in MYOS MD. The study assessed muscle protein synthesis in older adults under blinded conditions with an appropriate caloric control. The outcome was clear, “There was an overall increase in the rates of muscle protein synthesis with this product, Fortetropin.”
He also discussed the biological mechanism. Fortetropin appears to suppress myostatin, a negative regulator of muscle growth. Myostatin functions as a biological brake. Elevated myostatin signaling limits muscle hypertrophy and contributes to muscle loss.
Pharmaceutical companies have invested billions into anti myostatin therapies. Dr. Evans noted that drug developers have been “feverishly attempting” to develop anti myostatin agents. Fortetropin represents a natural bioactive approach shown in human research to upregulate muscle protein synthesis.
He acknowledged initial skepticism prior to conducting the study. After blinded analysis, the anabolic signal was evident. Preclinical models also suggest that Fortetropin may help maintain protein synthesis during hypocaloric states. This has implications for individuals undergoing medically supervised weight loss, recovering from illness, or experiencing periods of inactivity.
Fortetropin is not a replacement for resistance training. It is not a replacement for dietary protein. It supports the biological machinery that allows muscle to respond to both.
Inactivity Accelerates Muscle Loss
Dr. Evans described research involving ten days of bed rest in healthy older adults. Participants lost approximately one kilogram of muscle from their legs alone. Muscle protein synthesis declined by forty percent. Recovery required months of rehabilitation.
Older adults lose muscle three times faster than younger individuals during inactivity.
These findings reinforce a central principle. Muscle is dynamic. It responds rapidly to stimulus and rapidly to disuse. Strategies that preserve muscle protein synthesis during stress, caloric restriction, or inactivity may meaningfully influence recovery and long term function.
A Muscle First Framework for Longevity
Near the close of the interview, Dr. Evans summarized the philosophy succinctly, “Aging isn’t passive. It’s a negotiation between your choices and your biology.”
Muscle preservation must be central to that negotiation. And Fortetropin has been shown to upregulate muscle protein synthesis in older adults. In the context of resistance training and adequate protein intake, it supports a muscle first strategy designed to protect metabolic function and independence.
The goal is no longer simply weight management. It is preservation of metabolically active tissue.
Because muscle built today is independence retained tomorrow.